These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1175 related items for PubMed ID: 20586932

  • 21. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma.
    Yang XH, Yamagiwa S, Ichida T, Matsuda Y, Sugahara S, Watanabe H, Sato Y, Abo T, Horwitz DA, Aoyagi Y.
    J Hepatol; 2006 Aug; 45(2):254-62. PubMed ID: 16600416
    [Abstract] [Full Text] [Related]

  • 22. Overexpression of Toll-like receptor 2/4 on monocytes modulates the activities of CD4(+)CD25(+) regulatory T cells in chronic hepatitis B virus infection.
    Zhang Y, Lian JQ, Huang CX, Wang JP, Wei X, Nan XP, Yu HT, Jiang LL, Wang XQ, Zhuang Y, Li XH, Li Y, Wang PZ, Robek MD, Bai XF.
    Virology; 2010 Feb 05; 397(1):34-42. PubMed ID: 19945134
    [Abstract] [Full Text] [Related]

  • 23. CD4+CD25+ Treg derived from hepatocellular carcinoma mice inhibits tumor immunity.
    Chen X, Du Y, Huang Z.
    Immunol Lett; 2012 Feb 05; 148(1):83-9. PubMed ID: 23000301
    [Abstract] [Full Text] [Related]

  • 24. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW, Zhou RB, Yao YM, Zhu XM, Yin YM, Zhao GJ, Dong N, Sheng ZY.
    J Pharmacol Exp Ther; 2010 Dec 05; 335(3):553-61. PubMed ID: 20843956
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
    Shao X, Ma J, Jia S, Yang L, Wang W, Jin Z.
    Front Cell Infect Microbiol; 2017 Dec 05; 7():472. PubMed ID: 29181338
    [Abstract] [Full Text] [Related]

  • 27. Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B.
    Yang G, Liu A, Xie Q, Guo TB, Wan B, Zhou B, Zhang JZ.
    Int Immunol; 2007 Feb 05; 19(2):133-40. PubMed ID: 17182968
    [Abstract] [Full Text] [Related]

  • 28. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS, Krishnadas DK, Agrawal B.
    Int Immunol; 2007 Mar 05; 19(3):227-37. PubMed ID: 17289657
    [Abstract] [Full Text] [Related]

  • 29. Clinical prognostic value of CD4+CD25+FOXP3+regulatory T cells in peripheral blood of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma patients.
    Li F, Guo Z, Lizée G, Yu H, Wang H, Si T.
    Clin Chem Lab Med; 2014 Sep 05; 52(9):1357-65. PubMed ID: 24646790
    [Abstract] [Full Text] [Related]

  • 30. Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.
    Méndez-Lagares G, Pozo-Balado MM, Genebat M, García Pergañeda A, Leal M, Pacheco YM.
    J Infect Dis; 2012 May 15; 205(10):1501-9. PubMed ID: 22457273
    [Abstract] [Full Text] [Related]

  • 31. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
    Bocian K, Borysowski J, Wierzbicki P, Wyzgal J, Klosowska D, Bialoszewska A, Paczek L, Górski A, Korczak-Kowalska G.
    Nephrol Dial Transplant; 2010 Mar 15; 25(3):710-7. PubMed ID: 19903662
    [Abstract] [Full Text] [Related]

  • 32. Enhanced ability of regulatory T cells in chronic hepatitis C patients with persistently normal alanine aminotransferase levels than those with active hepatitis.
    Itose I, Kanto T, Kakita N, Takebe S, Inoue M, Higashitani K, Miyazaki M, Miyatake H, Sakakibara M, Hiramatsu N, Takehara T, Kasahara A, Hayashi N.
    J Viral Hepat; 2009 Dec 15; 16(12):844-52. PubMed ID: 19486278
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer.
    Pedroza-Gonzalez A, Verhoef C, Ijzermans JN, Peppelenbosch MP, Kwekkeboom J, Verheij J, Janssen HL, Sprengers D.
    Hepatology; 2013 Jan 15; 57(1):183-94. PubMed ID: 22911397
    [Abstract] [Full Text] [Related]

  • 36. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.
    Ormandy LA, Hillemann T, Wedemeyer H, Manns MP, Greten TF, Korangy F.
    Cancer Res; 2005 Mar 15; 65(6):2457-64. PubMed ID: 15781662
    [Abstract] [Full Text] [Related]

  • 37. Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response.
    Stoop JN, Woltman AM, Biesta PJ, Kusters JG, Kuipers EJ, Janssen HL, van der Molen RG.
    Hepatology; 2007 Sep 15; 46(3):699-705. PubMed ID: 17654744
    [Abstract] [Full Text] [Related]

  • 38. Increased CD4+CD25+ regulatory T cells correlate with poor short-term outcomes in hepatitis B virus-related acute-on-chronic liver failure patients.
    Shen C, Yan WZ, Zhao CY, Che HH, Liu XY, Liu ZZ, Wang YD, Wang W, Li M, Gao J.
    J Microbiol Immunol Infect; 2015 Apr 15; 48(2):137-46. PubMed ID: 24388581
    [Abstract] [Full Text] [Related]

  • 39. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
    Luan YY, Yao YM, Zhang L, Dong N, Zhang QH, Yu Y, Sheng ZY.
    Mol Immunol; 2011 Oct 15; 49(1-2):219-26. PubMed ID: 21963221
    [Abstract] [Full Text] [Related]

  • 40. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
    Bianchini R, Bistoni O, Alunno A, Petrillo MG, Ronchetti S, Sportoletti P, Bocci EB, Nocentini G, Gerli R, Riccardi C.
    Eur J Immunol; 2011 Aug 15; 41(8):2269-78. PubMed ID: 21557210
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 59.